Spark Investment Management LLC Veracyte, Inc. Transaction History

Spark Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$20.78 - $29.99 $226,231 - $326,501	-10,887 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$23.87 - $30.93 $3.97 Million - $5.15 Million	-166,413 Reduced 93.86%	10,887 $261,000
Q2 2019 Aug 12, 2019	SELL	$22.1 - $28.56 $3.23 Million - $4.17 Million	-146,100 Reduced 45.18%	177,300 $5.05 Million
Q1 2019 May 07, 2019	BUY	$12.0 - $25.76 $1.81 Million - $3.88 Million	150,600 Added 87.15%	323,400 $8.09 Million
Q4 2018 Feb 12, 2019	BUY	$9.15 - $14.85 $854,610 - $1.39 Million	93,400 Added 117.63%	172,800 $2.17 Million
Q3 2018 Nov 13, 2018	BUY	$9.55 - $12.64 $636,985 - $843,088	66,700 Added 525.2%	79,400 $758,000
Q2 2018 Aug 08, 2018	SELL	$5.39 - $9.66 $117,502 - $210,588	-21,800 Reduced 63.19%	12,700 $118,000
Q4 2017 Feb 12, 2018	SELL	$6.05 - $9.37 $265,437 - $411,099	-43,874 Reduced 55.98%	34,500 $225,000
Q3 2017 Nov 13, 2017	BUY	$7.81 - $8.77 $612,100 - $687,339	78,374	78,374 $687,000

308

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.83B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.